Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice Read more →

Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope Read more →

Inside the growing world of biopharma prediction markets Read more →